Structures by: Timiri A. K.
Total: 7
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(4-methoxyphenyl)acetamide
C13H15N5O2S
IUCrData (2018) 3, 4 x180600
a=18.2763(6)Å b=7.5909(2)Å c=20.0571(6)Å
α=90° β=90° γ=90°
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(pyridin-2-yl)acetamide
C11H12N6OS
Acta Crystallographica Section E (2018) 74, 5 718-723
a=7.2341(2)Å b=9.3852(2)Å c=9.7971(2)Å
α=95.8200(10)° β=91.1160(10)° γ=105.6820(10)°
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(pyrazin-2-yl)acetamide
C10H11N7OS
Acta Crystallographica Section E (2018) 74, 5 718-723
a=12.1333(5)Å b=8.1561(3)Å c=12.8442(5)Å
α=90° β=94.307(3)° γ=90°
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(3-nitrophenyl)acetamide monohydrate
C12H12N6O3S,H2O
Acta Crystallographica Section E (2016) 72, 8 1171-1175
a=7.23260(10)Å b=14.3442(2)Å c=14.0940(3)Å
α=90° β=90° γ=90°
<i>N</i>-(2-Chlorophenyl)-2-[(4,6-diaminopyrimidin-2-yl)sulfanyl]acetamide
C12H12ClN5OS
Acta Crystallographica Section E (2016) 72, 8 1171-1175
a=7.2528(2)Å b=7.6249(3)Å c=13.0649(4)Å
α=91.410(2)° β=105.924(2)° γ=94.647(2)°
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(2,4-dimethylphenyl)acetamide
C14H17N5OS
Acta Crystallographica Section E (2017) 73, 7 996-1000
a=23.7716(6)Å b=7.0073(2)Å c=9.0909(2)Å
α=90° β=90.086(2)° γ=90°
2-[(4,6-Diaminopyrimidin-2-yl)sulfanyl]-<i>N</i>-(3-methoxyphenyl)acetamide
C13H15N5O2S
Acta Crystallographica Section E (2017) 73, 7 996-1000
a=8.014(5)Å b=8.724(5)Å c=12.068(5)Å
α=106.561(5)° β=97.888(5)° γ=110.461(5)°